Hoffmann-La Roche
Jump to navigation
Jump to search
 Hoffmann-La Roche  (Big pharma)   | |
|---|---|
 | |
| Formation | 1896 |
| Founder | Fritz Hoffmann-La Roche |
| Member of | Alliance for Biosecurity, European Policy Centre |
| Founder of | Diazepam |
| Subpage | •Hoffmann-La Roche/President |
nCoV-2019 antibody test
Mai, 2020: The test is the third granted emergency approval by the FDA in a urgent procedure and the first commercially available. It gives quick results (18 Min.) and will be accepted worldwide in what has been touted one of Roche's biggest deals. [1] The test is not based on the PCR method (which directly detects parts of viral RNA) but addresses antibodies built by the immune system after 1-2 weeks of contact. These may not be specific with a risk for false positives stemming from common cold viruses. The test is self-approved by Roche with the FDA merely giving green light. [2]
Employee on Wikispooks
| Employee | Job |
|---|---|
| André Hoffmann | Vice-Chairman |
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
